Insmed Incorporated
Insmed Incorporated INSM Peers
See (INSM) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
---|---|---|---|---|---|---|
INSM | $103.52 | +0.08% | 19.7B | -17.46 | -$5.93 | N/A |
ONC | $296.46 | +0.55% | 32.9B | -81.45 | -$3.64 | N/A |
WBA | $11.59 | +0.52% | 10B | -1.59 | -$7.29 | +4.32% |
HROWL | $25.23 | -0.36% | 1.4B | N/A | N/A | N/A |
HROWM | $26.29 | -0.71% | 1.3B | N/A | N/A | +11.29% |
LFMDP | $24.25 | +0.37% | 1.1B | -10.73 | -$2.26 | N/A |
LFMD | $10.67 | -1.66% | 484.9M | -32.33 | -$0.33 | N/A |
HITI | $2.37 | -1.66% | 191.7M | -26.28 | -$0.09 | N/A |
PETS | $3.98 | +5.85% | 82.2M | 398.00 | $0.01 | N/A |
YI | $7.38 | +0.41% | 63.4M | -3.37 | -$2.17 | N/A |
Stock Comparison
INSM vs ONC Comparison
INSM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INSM stands at 19.7B. In comparison, ONC has a market cap of 32.9B. Regarding current trading prices, INSM is priced at $103.52, while ONC trades at $296.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INSM currently has a P/E ratio of -17.46, whereas ONC's P/E ratio is -81.45. In terms of profitability, INSM's ROE is -4.47%, compared to ONC's ROE of -0.12%. Regarding short-term risk, INSM is more volatile compared to ONC. This indicates potentially higher risk in terms of short-term price fluctuations for INSM.
INSM vs WBA Comparison
INSM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INSM stands at 19.7B. In comparison, WBA has a market cap of 10B. Regarding current trading prices, INSM is priced at $103.52, while WBA trades at $11.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INSM currently has a P/E ratio of -17.46, whereas WBA's P/E ratio is -1.59. In terms of profitability, INSM's ROE is -4.47%, compared to WBA's ROE of -0.70%. Regarding short-term risk, INSM is more volatile compared to WBA. This indicates potentially higher risk in terms of short-term price fluctuations for INSM.
INSM vs HROWL Comparison
INSM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INSM stands at 19.7B. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, INSM is priced at $103.52, while HROWL trades at $25.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INSM currently has a P/E ratio of -17.46, whereas HROWL's P/E ratio is N/A. In terms of profitability, INSM's ROE is -4.47%, compared to HROWL's ROE of -0.36%. Regarding short-term risk, INSM is more volatile compared to HROWL. This indicates potentially higher risk in terms of short-term price fluctuations for INSM.
INSM vs HROWM Comparison
INSM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INSM stands at 19.7B. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, INSM is priced at $103.52, while HROWM trades at $26.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INSM currently has a P/E ratio of -17.46, whereas HROWM's P/E ratio is N/A. In terms of profitability, INSM's ROE is -4.47%, compared to HROWM's ROE of -0.28%. Regarding short-term risk, INSM is more volatile compared to HROWM. This indicates potentially higher risk in terms of short-term price fluctuations for INSM.
INSM vs LFMDP Comparison
INSM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INSM stands at 19.7B. In comparison, LFMDP has a market cap of 1.1B. Regarding current trading prices, INSM is priced at $103.52, while LFMDP trades at $24.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INSM currently has a P/E ratio of -17.46, whereas LFMDP's P/E ratio is -10.73. In terms of profitability, INSM's ROE is -4.47%, compared to LFMDP's ROE of +2.33%. Regarding short-term risk, INSM is more volatile compared to LFMDP. This indicates potentially higher risk in terms of short-term price fluctuations for INSM.
INSM vs LFMD Comparison
INSM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INSM stands at 19.7B. In comparison, LFMD has a market cap of 484.9M. Regarding current trading prices, INSM is priced at $103.52, while LFMD trades at $10.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INSM currently has a P/E ratio of -17.46, whereas LFMD's P/E ratio is -32.33. In terms of profitability, INSM's ROE is -4.47%, compared to LFMD's ROE of +2.33%. Regarding short-term risk, INSM is less volatile compared to LFMD. This indicates potentially lower risk in terms of short-term price fluctuations for INSM.
INSM vs HITI Comparison
INSM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INSM stands at 19.7B. In comparison, HITI has a market cap of 191.7M. Regarding current trading prices, INSM is priced at $103.52, while HITI trades at $2.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INSM currently has a P/E ratio of -17.46, whereas HITI's P/E ratio is -26.28. In terms of profitability, INSM's ROE is -4.47%, compared to HITI's ROE of -0.07%. Regarding short-term risk, INSM is less volatile compared to HITI. This indicates potentially lower risk in terms of short-term price fluctuations for INSM.
INSM vs PETS Comparison
INSM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INSM stands at 19.7B. In comparison, PETS has a market cap of 82.2M. Regarding current trading prices, INSM is priced at $103.52, while PETS trades at $3.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INSM currently has a P/E ratio of -17.46, whereas PETS's P/E ratio is 398.00. In terms of profitability, INSM's ROE is -4.47%, compared to PETS's ROE of +0.00%. Regarding short-term risk, INSM is less volatile compared to PETS. This indicates potentially lower risk in terms of short-term price fluctuations for INSM.
INSM vs YI Comparison
INSM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INSM stands at 19.7B. In comparison, YI has a market cap of 63.4M. Regarding current trading prices, INSM is priced at $103.52, while YI trades at $7.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INSM currently has a P/E ratio of -17.46, whereas YI's P/E ratio is -3.37. In terms of profitability, INSM's ROE is -4.47%, compared to YI's ROE of +0.11%. Regarding short-term risk, INSM is more volatile compared to YI. This indicates potentially higher risk in terms of short-term price fluctuations for INSM.
INSM vs RAD Comparison
INSM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INSM stands at 19.7B. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, INSM is priced at $103.52, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INSM currently has a P/E ratio of -17.46, whereas RAD's P/E ratio is -0.05. In terms of profitability, INSM's ROE is -4.47%, compared to RAD's ROE of +2.76%. Regarding short-term risk, INSM is less volatile compared to RAD. This indicates potentially lower risk in terms of short-term price fluctuations for INSM.
INSM vs RNTX Comparison
INSM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INSM stands at 19.7B. In comparison, RNTX has a market cap of 30.6M. Regarding current trading prices, INSM is priced at $103.52, while RNTX trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INSM currently has a P/E ratio of -17.46, whereas RNTX's P/E ratio is -0.48. In terms of profitability, INSM's ROE is -4.47%, compared to RNTX's ROE of -1.12%. Regarding short-term risk, INSM is less volatile compared to RNTX. This indicates potentially lower risk in terms of short-term price fluctuations for INSM.
INSM vs NEUP Comparison
INSM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INSM stands at 19.7B. In comparison, NEUP has a market cap of 15.8M. Regarding current trading prices, INSM is priced at $103.52, while NEUP trades at $8.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INSM currently has a P/E ratio of -17.46, whereas NEUP's P/E ratio is 0.45. In terms of profitability, INSM's ROE is -4.47%, compared to NEUP's ROE of +0.31%. Regarding short-term risk, INSM is less volatile compared to NEUP. This indicates potentially lower risk in terms of short-term price fluctuations for INSM.
INSM vs MEDS Comparison
INSM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INSM stands at 19.7B. In comparison, MEDS has a market cap of 13.3M. Regarding current trading prices, INSM is priced at $103.52, while MEDS trades at $7.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INSM currently has a P/E ratio of -17.46, whereas MEDS's P/E ratio is -0.31. In terms of profitability, INSM's ROE is -4.47%, compared to MEDS's ROE of +0.22%. Regarding short-term risk, INSM is less volatile compared to MEDS. This indicates potentially lower risk in terms of short-term price fluctuations for INSM.
INSM vs ATNFW Comparison
INSM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INSM stands at 19.7B. In comparison, ATNFW has a market cap of 12.9M. Regarding current trading prices, INSM is priced at $103.52, while ATNFW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INSM currently has a P/E ratio of -17.46, whereas ATNFW's P/E ratio is N/A. In terms of profitability, INSM's ROE is -4.47%, compared to ATNFW's ROE of -1.41%. Regarding short-term risk, INSM is less volatile compared to ATNFW. This indicates potentially lower risk in terms of short-term price fluctuations for INSM.
INSM vs CJJD Comparison
INSM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INSM stands at 19.7B. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, INSM is priced at $103.52, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INSM currently has a P/E ratio of -17.46, whereas CJJD's P/E ratio is -0.46. In terms of profitability, INSM's ROE is -4.47%, compared to CJJD's ROE of -0.30%. Regarding short-term risk, INSM is less volatile compared to CJJD. This indicates potentially lower risk in terms of short-term price fluctuations for INSM.
INSM vs SSY Comparison
INSM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INSM stands at 19.7B. In comparison, SSY has a market cap of 8.7M. Regarding current trading prices, INSM is priced at $103.52, while SSY trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INSM currently has a P/E ratio of -17.46, whereas SSY's P/E ratio is -3.15. In terms of profitability, INSM's ROE is -4.47%, compared to SSY's ROE of +0.12%. Regarding short-term risk, INSM is less volatile compared to SSY. This indicates potentially lower risk in terms of short-term price fluctuations for INSM.
INSM vs MDVL Comparison
INSM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INSM stands at 19.7B. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, INSM is priced at $103.52, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INSM currently has a P/E ratio of -17.46, whereas MDVL's P/E ratio is -0.05. In terms of profitability, INSM's ROE is -4.47%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, INSM is less volatile compared to MDVL. This indicates potentially lower risk in terms of short-term price fluctuations for INSM.
INSM vs LFLYW Comparison
INSM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INSM stands at 19.7B. In comparison, LFLYW has a market cap of 658.9K. Regarding current trading prices, INSM is priced at $103.52, while LFLYW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INSM currently has a P/E ratio of -17.46, whereas LFLYW's P/E ratio is -0.06. In terms of profitability, INSM's ROE is -4.47%, compared to LFLYW's ROE of +0.34%. Regarding short-term risk, INSM is more volatile compared to LFLYW. This indicates potentially higher risk in terms of short-term price fluctuations for INSM.
INSM vs LFLY Comparison
INSM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INSM stands at 19.7B. In comparison, LFLY has a market cap of 539.6K. Regarding current trading prices, INSM is priced at $103.52, while LFLY trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INSM currently has a P/E ratio of -17.46, whereas LFLY's P/E ratio is -0.10. In terms of profitability, INSM's ROE is -4.47%, compared to LFLY's ROE of +0.34%. Regarding short-term risk, INSM is more volatile compared to LFLY. This indicates potentially higher risk in terms of short-term price fluctuations for INSM.
INSM vs BIMI Comparison
INSM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INSM stands at 19.7B. In comparison, BIMI has a market cap of 2.8K. Regarding current trading prices, INSM is priced at $103.52, while BIMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INSM currently has a P/E ratio of -17.46, whereas BIMI's P/E ratio is N/A. In terms of profitability, INSM's ROE is -4.47%, compared to BIMI's ROE of -2.93%. Regarding short-term risk, INSM is more volatile compared to BIMI. This indicates potentially higher risk in terms of short-term price fluctuations for INSM.